S&P 500 7,676.77 +0.70%
Nasdaq 26,169.38 +0.82%
S&P/TSX 35,944.16 +0.44%
Apple 343.91 −1.10%
Nvidia 216.00 +2.39%
Microsoft 532.60 +1.54%
Shopify 235.93 −0.13%
Royal Bank 284.26 +0.88%
CAD/USD 0.7134 −0.03%
CLOSED · 03:45 ET
Market ClerkRecap
Tue Oct 27 · markets closed1 signal on Oct 26140 insider buys this week · $73.9MCIRO short report next: Oct 30The week ahead

FBRX

Forte Biosciences, Inc.
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
No price history available

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

Who holds it

SEC 13F · LATEST QUARTER PER FUND
None of the 15 tracked funds disclose FBRX in their latest 13F. The funds we follow.

13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.

Stakes of 5% or more

SCHEDULE 13D / 13G · LATEST PER HOLDER · TWO YEARS
Federated Hermes, Inc. and 4 related0.0%
SCHEDULE 13G/A · filed Sep 8 · passive · EDGAR ↗

A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.

Watch FBRX. Know when insiders buy.
One email the day a filing lands. Free.